Merck Fails To Force Trial Of Bellwether Fosamax Case
One of the bellwether plaintiffs in the multidistrict litigation over Merck & Co. Inc.'s osteoporosis drug Fosamax, who tried to drop her claims after Merck obtained a damaging deposition from one...To view the full article, register now.
Already a subscriber? Click here to view full article